Inactive

The Government proposes to make an award to Life Technologies Corporation for the purchase of custom TaqMan Array cards (product ID 4485460 special gene-ex, conf(4), quantity 700 from Thermo Fisher Sc... The Government proposes to make an award to Life Technologies Corporation for the purchase of custom TaqMan Array cards (product ID 4485460 special gene-ex, conf(4), quantity 700 from Thermo Fisher Scientific. The TaqMan Array Cards (TAC) are the only product that can be used for the spotting of reagents on 384 well cards which will be used for multi-pathogen testing of post-mortem specimens from enrolled cases in the Child Health and Mortality Prevention Surveillance (CHAMPS) program. The TACs are microfluidic arrays containing ~20-40 CDC-developed PCR assays in customized configurations. This technology has been used by CDC for over 15 years, and evaluations of lab-created and clinical specimens have demonstrated that TAC has similar sensitivity and specificity to individual PCR reactions, but allows for higher throughput, reduced potential for contamination, lower cost, specimen conservation, and substantial improvement in ease of use for operator. Based on successful use of this product for other surveillance projects, it was selected for use in the Child Health and Morality Prevention Surveillance (CHAMPS) program. Going forward continued use of this product is required for continuity of specimen testing in accordance with CHAMPS program-specific protocols and funding. This notice of intent is not a request for competitive quotations; however, all quotations/responses received within seven (7) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at uid1@cdc.gov.